Outlook Therapeutics COO departs, named Senior Advisor in organizational realignment

Outlook Therapeutics, Inc.

Terry Dagnon ceased as Chief Operations Officer effective November 30, 2023.
Appointed as Senior Advisor under company's strategic realignment for ONS-5010 priorities.
Dagnon continues to receive current base salary and benefits under existing employment agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Terry Dagnon

Senior Advisor

OTLK · Outlook Therapeutics, Inc.

Effective: 2023-11-30
Filed: December 6, 2023, 6:59 PM ET

Terry Dagnon ceased to serve as the Company’s Chief Operations Officer and an executive officer of the Company and was appointed as Senior Advisor.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Terry Dagnon was appointed as Senior Advisor at Outlook Therapeutics, Inc..

Action: appointed as Senior Advisor
Role: Senior Advisor

Exact text from the filing

Terry Dagnon ceased to serve as the Company’s Chief Operations Officer and an executive officer of the Company and was appointed as Senior Advisor.

View on SEC.gov

Outlook Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-124025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.